Form 4 for CATX Perspective Therapeutics, Inc.
Accepted 2024-06-13 00:00:00 ET · period of report 2024-06-13 · accession 0000950170-24-073145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-13 | 2024-06-13 | CATX | Spoor Johan M. | CEO, Dir | P - Purchase | $1.17 | +100.0K | 137.6K | +266% | +$117.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-13 | P | A | 100,000 | $1.17 | 137,572 | D | — | — | (F1) The price in column 4 is a weighted average price. The prices actually paid ranged from $1.1650 to $1.1800. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or a securityholder of the issuer, full information regarding the number of shares purchased at each separate price within the range. |